Jornay PM - Evening-Dosed Methylphenidate for ADHD
Jornay PM - Evening-Dosed Methylphenidate for ADHD
August 12, 2019 (Issue: 1578)
The FDA has approved Jornay PM (Ironshore), a
capsule formulation of methylphenidate with a
delayed-release outer layer and an extended-release
inner layer, for once-nightly treatment of attention-deficit hyperactivity disorder (ADHD) in patients...more
- Drugs for ADHD. Med Lett Drugs Ther 2015; 57:37.
- Cotempla XR-ODT – another long-acting methylphenidate for ADHD. Med Lett Drugs Ther 2017; 59:183.
- A Childress et al. Single-dose pharmacokinetics of HLD200, a delayed-release and extended-release methylphenidate formulation, in healthy adults and in adolescents and children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2018; 28:10.
- T Liu et al. Pharmacokinetics of HLD200, a delayed-release and extended-release methylphenidate: evaluation of dose proportionality, food effect, multiple-dose modeling, and comparative bioavailability with immediate-release methylphenidate in healthy adults. J Child Adolesc Psychopharmacol 2019; 29:181.
- AC Childress et al. Efficacy and safety of delayed-release and extended-release methylphenidate (DR/ER-MPH) in children with ADHD: results from a pivotal phase 3 classroom trial. J Am Acad Child Adolesc Psychiatry 2018; 57:s166. Available at: www.jaacap.org. Accessed August 1, 2019.
- FDA Center for Drug Evaluation and Research. Summary review. Available at: www.accessdata.fda.gov. Accessed August 1, 2019.
- SR Pliszka et al. Efficacy and safety of HLD200, delayed-release and extended-release methylphenidate, in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2017; 27:474.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Jornay PM - Evening-Dosed Methylphenidate for ADHD
Article code: 1578b
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
